Avik Chatterjee MD, MPH

Associate Professor, General Internal Medicine

801 Massachusetts Ave | (617) 414-7399
Avik Chatterjee
Sections

General Internal Medicine

Centers

Clinical Addiction Research and Education Unit

Evans Center for Interdisciplinary Biomedical Research

Biography

Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in marginalized populations, and interventions on social determinants of health, such as food insecurity. He has an additional interest in racism and health care, particularly its manifestations in medical education and training.

Education

Medicine, MD, University of North Carolina at Chapel Hill

Publications

Published on 3/13/2026

Silcox J, Summers C, Zaragoza S, Case P, Chatterjee A, Porter S, Green TC. Erratum to "Exploring placemaking in Boston's low-threshold transitional housing locations" [Health Place 98C (2026) 103634]. Health Place. 2026 Mar 13; 103650. PMID: 41826090.

Published on 3/5/2026

Barbosa C, Chen Q, Sahinkoc M, Zarkin GA, Dowd W, Villani J, Barocas JA, Cerdá M, Chatterjee A, Fareed N, Hyder A, Keyes KM, Larochelle MR, Linas BP, Roberts SM, Schackman BR, Seiber E, Wakeman SE, Knudsen AB, Chhatwal J. Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach. Addiction. 2026 Mar 05. PMID: 41786317.

Published on 2/24/2026

Fox AD, Messmer SE, Hayes BT, Salisbury-Afshar E, Chatterjee A, Jakubowski AU. Low-threshold Buprenorphine: Proposing the Ideal Service Model to Engage People With Severe Opioid Use Disorder. J Addict Med. 2026 Feb 24. PMID: 41731662.

Published on 2/17/2026

Silcox J, Summers C, Zaragoza S, Case P, Chatterjee A, Porter S, Green TC. Exploring placemaking in Boston's low-threshold transitional housing locations. Health Place. 2026 Feb 17; 98:103634. PMID: 41707515.

Published on 1/18/2026

Summers C, Silcox J, Zaragoza S, Rapisarda S, Edelmann A, Chatterjee A, Green TC. Real time, on-site drug checking in low-threshold housing communities. Harm Reduct J. 2026 Jan 18; 23(1):33. PMID: 41547849.

Published on 12/24/2025

Barrera I, Wang G, Rajakumar B, Muthupalaniappan S, Cronin AE, Chatterjee A. Mobile addiction treatment units: a narrative review. Addict Sci Clin Pract. 2025 Dec 24; 20(1):99. PMID: 41444990.

Published on 12/5/2025

Li Z, Chiddawar TV, Shaw LC, Dennis A, Lieberman A, Kingsepp A, Trinidad AJ, Tuazon E, Welch AE, Chatterjee A, Schackman BR, Enns EA, Walley AY, Green TC, Wagner KD, Winograd RP, Behrends CN, Crable EL, Marshall BDL, Zang X. A descriptive study of drug overdose epidemics, overdose prevention efforts, and opioid settlement fund distribution across six states. Int J Drug Policy. 2026 Jan; 147:105100. PMID: 41351927.

Published on 12/2/2025

Stahl N, Bositis A, Damato-MacPherson C, Weiner R, Conole D, McAlearney AS, Stadler HM, Chatterjee A. Expedited referrals from community health center to opioid treatment program: innovative approaches to improving access to methadone treatment for patients who use opioids and experience homelessness. Addict Sci Clin Pract. 2025 Dec 02; 20(1):94. PMID: 41331878.

Published on 10/30/2025

Chatterjee A, Chase RP, Chahine RA, Davis J, Dsouza N, Ellison S, Bagley SM, Fisher T, Glasgow L, Harris MTH, Huang TT, Holloway J, Lounsbury DW, Oga E, Asman K, Roberts SM, Sabounchi N, Surratt HL, Lines LM, Stadler HW, Taylor JL, Davis A. Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths. J Subst Use Addict Treat. 2026 Jan; 180:209828. PMID: 41175975.

Published on 9/26/2025

Park JN, McKee H, Ramsey SE, Rich JD, Green TC, Frank HE, Chatterjee A, Rosen JG. Feasibility and Acceptability of Restroom Motion Sensors for Detecting Overdoses. Subst Use Addctn J. 2025 Sep 26; 29767342251370822. PMID: 41006965.

View full list of 83 publications.